Browsing by Author "Masana, Luís"

Sort by: Order: Results:

  • Masana, Luís; Correig, Eudald; Rodríguez-Borjabad, Cèlia; Anoro, Eva; Arroyo-Díaz, Juan Antonio; Jericó, Carlos; Pedragosa, Angels; Miret, Marcel·la; Näf, Silvia; Pardo, Anna; Perea, Verónica; Pérez-Bernalte, Rosa; Plana, Nuria; Ramírez-Montesinos, Rafael; Royuela, Meritxell; Soler, Cristina; Urquizu-Padilla, Maria; Masana, Luís; Pedro-Botet, Juan Carlos; The Stacov-Xula Research Group (Oxford University Press, 2022)
    Aim: Assessing the effect of statin therapy at hospital admission for COVID-19 on in-hospital mortality. Methods and results: Retrospective observational study. Patients taking statins were 11 years older and had significantly ...
  • Zamora, Alberto; Masana, Luís; Comas Cufí, Marc; Vila, Alex; Plana, Nuria; Garcıa-Gil, Maria; Alves-Cabratosa, Lia; Marrugat de la Iglesia, Jaume; Roman Degano, Irene; Ramos, Rafel; XULA and ISV-Girona groups (Elsevier, 2017)
    BACKGROUND: Familial hypercholesterolemia (FH), the most frequent hereditary cause of premature coronary heart disease (CHD), is underdiagnosed and insufficiently treated. OBJECTIVES: The objectives of the study were to ...
  • Masana, Luís; Zamora, Alberto; Plana, Nuria; Comas Cufí, Marc; Garcıa-Gil, Maria; Martí, Ruth; Ponjoan, Anna; Alves-Cabratosa, Lia; Elosua Llanos, Roberto; Marrugat de la Iglesia, Jaume; Dégano, Irene R.; Ramos, Rafel (MDPI, 2019)
    In the statin era, the incidence of atherosclerotic cardiovascular diseases (ASCVD) in patients with familial hypercholesterolemia (FH) has not been updated. We aimed to determine the incidence of ASCVD in patients with ...
  • Ascaso Gimilio, Juan Francisco; Civeira, Fernando; Guijarro, Carlos; López Miranda, José; Masana, Luís; Mostaza, José María; Pedro-Botet, Juan Carlos; Pintó Sala, Xavier; Valdivielso, Pedro (Elsevier, 2019)
    A group of experts convened by the Spanish Society of Arteriosclerosis (SEA) has been in charge of updating the SEA document on the indications of PCSK9 inhibitors (PCSK9i) in clinical practice that was published in 2016. ...
  • Masana, Luís; Correig, Eudald; Ibarretxe, Daiana; Anoro, Eva; Arroyo-Díaz, Juan Antonio; Jericó, Carlos; Guerrero, Carolina; Miret, Marcel·la; Näf, Silvia; Pardo, Anna; Perea, Verónica; Pérez-Bernalte, Rosa; Plana, Nuria; Ramírez-Montesinos, Rafael; Royuela, Meritxell; Soler, Cristina; Urquizu-Padilla, Maria; Zamora, Alberto; Pedro-Botet, Juan Carlos; The Stacov-Xula Research Group (Nature Research, 2021)
    Lipids are indispensable in the SARS-CoV-2 infection process. The clinical significance of plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to ascertain the association of the plasma lipid ...
  • Rehues, Pere; Girona, Josefa; Guardiola, Montse; Plana, Nuria; Scicali, Roberto; Piro, Salvatore; Muñiz-Grijalvo, Ovidio; Díaz Díaz, José Luis; Recasens, Lluís; Pinyol, Marta; Rosales, Roser; Esteban, Yaiza; Amigó, Núria; Masana, Luís; Ibarretxe, Daiana; Ribalta, Josep (MDPI, 2023)
    Atherosclerosis is a chronic inflammatory disease caused by the accumulation of cholesterol in the intima. Proprotein convertase subtilisin/kexin type 9 inhibitors (iPCSK9) can reduce low-density lipoprotein (LDL) cholesterol ...
  • Guijarro, Carlos; Civeira, Fernando; López Miranda, José; Masana, Luís; Pedro-Botet, Juan Carlos; Pintó Sala, Xavier; Valdivielso, Pedro; Mostaza, José María (Elsevier, 2022)
    Aims: During 2019 and 2020 a series of meetings over the country were carried out, with the aim of explaining the methodology and criteria for the ellaboration of the recommendations on the use of iPCSK9, published by the ...
  • Zamora, Alberto; Ramos, Rafel; Comas Cufí, Marc; García Gil, Maria; Martí-Lluch, Ruth; Plana, Nuria; Alves-Cabratosa, Lia; Ponjoan, Anna; Rodríguez-Borjabad, Cèlia; Ibarretxe, Daiana; Roman Degano, Irene; Marrugat de la Iglesia, Jaume; Elosua Llanos, Roberto; Martin-Urda Diez-Canseco, Anabel; Masana, Luís (Nature Research, 2023)
    Familial hypercholesterolemia (FH) is an autosomal dominant disease that has a prevalence of approximately 1/250 inhabitants and is the most frequent cause of early coronary heart disease (CHD). We included 1.343.973 women ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking